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The ability to establish lifelong latency after primary
infection is a common denominator of large DNA
viruses of the Herpesviridae family. Herpes viruses are
endemic to humans worldwide and contribute to the
meta-genome of 70-100% of the world’s population. The
significance of herpes viruses as pathogens has been
increasingly recognized during the past few decades,
with the escalation in the number of patients under-
going immunosuppressive therapy after organ or bone
marrow transplantation, and the rising incidence of
AIDS. The ability of these viruses to ensure their survi-
val by controlling cellular and immunological functions
[1] has focused attention on their potential role in the
development of vascular [2] and autoimmune syndromes
[3], cancers [4], and as possible co-factors for acquisition
of HIV [5]. In addition, these viruses have co-evolved
with, and shaped, the immune systems of their hosts.
The secrets of immunology can only be unlocked effi-
ciently by using well-adapted pathogens like these as
probes or keys to reveal fine adjustments in the immune
system compartments that have developed to control
these promiscuous and potentially deadly pathogens [6].
A search in PubMed [7] reveals that approximately
2000 papers focusing on herpes viruses are published
each year, many in well-established general virology
journals such as Journal of Virology and Virology.H o w -
ever, many others are published in specialist journals
focusing on immunology, pathology, transplantation,
and other areas. We aim for Herpesviridae to be our
community’s premier journal, bringing together the
interdisciplinary niches of research on this important
virus family Our goal is to focus the efforts of many
specialities into one journal by providing an Open
Access platform to gather and advance our scientific
efforts. Herpesviridae is in its infancy and is therefore
very flexible. In close co-operation with you – our
colleagues in the field – we hope to develop it into a
journal that we would all like to publish in and read.
For that reason, your input is vital for our ability to con-
tinue improving the journal. All input will be considered
carefully, and we will reply in a timely manner.
One of the major differences with Herpesviridae is the
focus on you as the author and how you can best pub-
lish your scientific work. Together with our internation-
ally well-renowned Editorial Board [8], consisting of
today’s and tomorrow’s leaders in our field, we will
apply a stringent but rapid peer-review process, with the
goal of giving authors a first decision within three weeks
after submission. Herpesviridae uses a closed peer
review system in which articles are reviewed by at least
two experts selected by the assigned Editors-in-Chief,
after an initial screening for suitability. With rapid pub-
lication in mind, we will weight the reviews that we
receive and prioritize the concerns raised, so that revi-
sion time and effort can be focused on the most press-
ing improvements.
Herpesviridae is an online publication only. Thus, arti-
cles will not be restricted in size, will be available imme-
diately after acceptance, and will be listed shortly
thereafter in PubMed. Furthermore, Herpesviridae is an
Open Access journal, enabling universal accessibility
and ensuring that your work reaches the widest possible
audience [9]. Authors will also retain the copyright for
their work. Universal accessibility, together with the fact
that Herpesviridae will publish high quality articles that
have undergone stringent peer review, will hopefully
result in high citations for published articles and conse-
quently a high Impact Factor in the future.
Herpesviridae publishes articles contributing to overall
knowledge on the role of herpes viruses in health and
disease. Articles from diverse fields, from experimental
biological studies to clinical studies, are welcome. We
aim to publish high-quality Reviews, Research articles,
Short Reports, Editorials, Letters to the Editor, Case
Reports, Clinical studies, and Meeting Reports of
special interest. The articles will be deposited in freely
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Alongside, all the advantages of Herpesviridae, the key
to the success of this journal ultimately rests with you,
our authors, reviewers, and readers. We are very excited
about Herpesviridae and the opportunities that it pro-
vides to our field. We hope you will seize the opportu-
nity to contribute and develop this new journal. We
welcome your comments, advice and submissions.
Author details
1Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
2Department of Ophthalmology, University of Pittsburgh School of Medicine,
Pittsburgh, PA, USA.
3Department of Immunology, University of Pittsburgh
School of Medicine, Pittsburgh, PA, USA.
4Department of Microbiology and
Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh,
PA, USA.
5Viral Immunobiology, Institute of Experimental Immunology,
University of Zürich, Zürich, Switzerland.
Received: 24 November 2010 Accepted: 7 December 2010
Published: 7 December 2010
References
1. Mossman KL, Ashkar AA: Herpesviruses and the innate immune response.
Viral Immunol 2005, 18:267-281.
2. Leinonen M, Saikku P: Evidence for infectious agents in cardiovascular
disease and atherosclerosis. Lancet Infect Dis 2002, 2:11-17.
3. Posnett DN: Herpesviruses and autoimmunity. Curr Opin Investig Drugs
2008, 9:505-514.
4. Martin D, Gutkind JS: Human tumor-associated viruses and new insights
into the molecular mechanisms of cancer. Oncogene 2008, 27(Suppl 2:):
S31-42.
5. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ: Herpes
simplex virus 2 infection increases HIV acquisition in men and women:
systematic review and meta-analysis of longitudinal studies. AIDS 2006,
20:73-83.
6. Zinkernagel RM: Immunology taught by viruses. Science 1996, 271:173-178.
7. PubMed. [http://www.ncbi.nlm.nih.gov/pubmed].
8. Herpesviridae Editorial Board. [http://www.herpesviridae.org/edboard/].
9. Suber P: Open access, impact, and demand. BMJ 2005, 330:1097-1098.
10. Which funding agencies explicitly allow direct use of their grants to
cover article processing charges?. [http://www.biomedcentral.com/info/
about/apcfaq#grants].
11. NIH Calls on Scientists to Speed Public Release of Research Publications.
[http://www.nih.gov/news/pr/feb2005/od-03.htm].
12. Wellcome Trust position statement in support of open and unrestricted
access to published research. [http://www.wellcome.ac.uk/node3302.html].
13. Howard Hughes Medical Institute Research Policies - Public access
publishing. [http://www.hhmi.org/about/research/sc320.pdf].
doi:10.1186/2042-4280-1-1
Cite this article as: Dzabic et al.: Welcome to Herpesviridae — a new
premier virology journal. Herpesviridae 2010 1:1. Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Dzabic et al. Herpesviridae 2010, 1:1
http://www.herpesviridae.org/content/1/1/1
Page 2 of 2